Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.76 USD | +2.76% |
|
+9.28% | +64.41% |
03/07 | Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added to S&P 1000 | CI |
03/07 | Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added to S&P 600 Health Care | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.41% | 2.16B | |
+25.21% | 46.56B | |
+45.38% | 41.67B | |
+0.31% | 41.16B | |
+33.67% | 32.4B | |
+20.80% | 28.18B | |
-6.35% | 28.1B | |
+49.19% | 14.52B | |
+47.51% | 13.74B | |
+3.07% | 12.17B |
- Stock Market
- Equities
- PTGX Stock
- News Protagonist Therapeutics, Inc.
- Transcript : Protagonist Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 02